UNSPSC 51393307: Etanterol

This classification denotes a bronchodilator with the molecular formula C18H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1597304395, chemically known as 5-amino-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)-m-xylene-alpha,alpha-diol but generally known as etanterol, which bears US NIH Compound Identifier 208937. European Medicines Agency schedules Etanterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07262MIG.

UNSPSC 51393307 Etanterol, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The code appears in the state and local market primarily through pharmaceutical and health-system solicitations, though the two recent opportunities tagged to this code—one procurement for naloxone and drug deactivation systems and one exploratory request for information on direct-to-manufacturer prescription programs—diverge substantially from etanterol's pharmaceutical classification. State and local health departments and human services commissions represent the primary issuing bodies pursuing activity in this general pharmaceutical-supply space, though etanterol itself does not emerge as a distinct procurement target in the available recent opportunities.

Seminole County, Florida solicited naloxone and safe drug deactivation systems through IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, requesting 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs for self-insured health plans and state agencies. Neither opportunity directly names etanterol procurement, and the code's actual recent activity in state and local markets remains unclear from available records. Firms pursuing business under this code should verify whether state purchasing offices are actively sourcing etanterol specifically or whether the code tagging reflects broader pharmaceutical-supply categorization misalignment.